Matches in Nanopublications for { ?s ?p "[Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP443257.RA6T7ab0tdUm494cOYmvEyph3GhBuAeW6PFSZzo1yn7oM130_assertion description "[Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP443257.RA6T7ab0tdUm494cOYmvEyph3GhBuAeW6PFSZzo1yn7oM130_provenance.
- assertion description "[Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP424975.RAWiWXsVoVzaoqhLc29Fvfm0SAqgQNvjeNa1WYwuupcn4130_assertion description "[Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424975.RAWiWXsVoVzaoqhLc29Fvfm0SAqgQNvjeNa1WYwuupcn4130_provenance.
- NP730240.RAQIJsm0P5VylpJh4jXZ090EOl20fr8VDncTxbouRs608130_assertion description "[Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP730240.RAQIJsm0P5VylpJh4jXZ090EOl20fr8VDncTxbouRs608130_provenance.
- NP730244.RAC9moGklIGEION1xV1nNt0Q-PtMhhL4HmXim-9IBhqiw130_assertion description "[Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP730244.RAC9moGklIGEION1xV1nNt0Q-PtMhhL4HmXim-9IBhqiw130_provenance.
- NP424764.RAk-h5nM3gQexX7NmlOWogQdBaa0zatqLN_h21qZM-HtU130_assertion description "[Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424764.RAk-h5nM3gQexX7NmlOWogQdBaa0zatqLN_h21qZM-HtU130_provenance.
- NP424842.RAqOEyCRvx6VIgS_kuHDXHwtPhrrrDlD6FVvSjcKTGqak130_assertion description "[Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP424842.RAqOEyCRvx6VIgS_kuHDXHwtPhrrrDlD6FVvSjcKTGqak130_provenance.
- NP425021.RArY4ALV_rv9BJ7_dW4jk5v8t3T93se5JLqETFLulivs4130_assertion description "[Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425021.RArY4ALV_rv9BJ7_dW4jk5v8t3T93se5JLqETFLulivs4130_provenance.
- NP730237.RAK3pUZDx6vRN2q0ebgPQbpzx5wrc8TeHcxNvzJAm1CQs130_assertion description "[Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP730237.RAK3pUZDx6vRN2q0ebgPQbpzx5wrc8TeHcxNvzJAm1CQs130_provenance.
- NP730248.RAEhQ7khioUEaqFIWf62n91nqH1b4pJlk3AUCElnAjDes130_assertion description "[Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP730248.RAEhQ7khioUEaqFIWf62n91nqH1b4pJlk3AUCElnAjDes130_provenance.